CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.

Quotes for CS MEDICA A/S

Right Now

+/-
-0.85
%
-10,30%
Latest
7.4
High
8.2
Low
7.1
Volume
138 603
Turnover (DKK)
1 035 357
Value (MDKK)
80,7

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Jørgen Flemming Ladefoged

Board

  • Anders Permin
  • Bo Unéus
  • Stein Løkstad

Largest Owners

Name Capital % Votes % Date
Gitte Henriksen 36,69 36,69 2021-09-14
Lone Henriksen 36,69 36,69 2021-09-14
Finn-Ove Henriksen and Nina Henriksen 3,34 3,34 2021-09-14
Ylber Rexhepi 2,32 2,32 2021-09-14
Tonoy Sayeed 1,46 1,46 2021-09-14
Taulant Bara 1,03 1,03 2021-09-14
Kent Eklund 1,03 1,03 2021-09-14
Thomas Gidlund 0,90 0,90 2021-09-14
Andreas Kjær 0,89 0,89 2021-09-14
Nils-Holger Olsson 0,77 0,77 2021-09-14
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Upcoming reports

  • 2021-11-18 Bokslutskommuniké 2021

  • 2021-12-09 Årsstämma 2021